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Abstract Changes in the glucosylation state of the glycogen
primer, glycogenin, or its association with glycogen synthase
are potential sites for regulation of glycogen synthesis. In this
study we found no evidence for hormonal control of the gluco-
sylation state of glycogenin in hepatocytes. However, using a
modi¢ed glycogen synthase assay that separates the product
into acid-soluble (glycogen) and acid-insoluble (proteoglycogen)
fractions we found that insulin and glucagon increase and de-
crease, respectively, the association of glycogen synthase with
an acid-insoluble substrate. The latter fraction had a higher
a⁄nity for UDP-glucose and accounted for between 5 and
21% of total activity depending on hormonal conditions. Phos-
phorylase overexpression mimicked the e¡ect of glucagon. It is
concluded that phosphorylase activation or overexpression
causes dissociation of glycogen synthase from proteoglycogen
causing inhibition of initiation of glycogen synthesis.
, 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Glycogen synthase has a key role in regulation of glycogen
synthesis [1]. Its activity is dependent on the phosphorylation
state of multiple sites [2] and on the concentration of glucose
6-P, which is a potent allosteric activator [3]. Glucose 6-P also
regulates glycogen synthase by making the enzyme a better
substrate for synthase phosphatase and by causing transloca-
tion of the protein form a soluble state to a particulate frac-
tion [4,5]. Liver glycogen synthase is also regulated by the
phosphorylated form of glycogen phosphorylase (phosphory-
lase-a) which is a potent allosteric inhibitor of glycogen syn-
thase phosphatase [1]. The phosphorylation state of liver
phosphorylase is dependent on the concentration of glucose,
which makes the enzyme a better substrate for phosphorylase
phosphatase [1] and on the concentration of glucose 6-P,
which also promotes dephosphorylation [6]. Activation of gly-
cogen synthase by glucose in liver cells is considered to in-
volve two convergent mechanisms: an increase in the cellular
content of glucose 6-P (which activates by direct and indirect
mechanisms) and dephosphorylation of phosphorylase a
which reverses the inhibition of glycogen synthase phospha-
tase [1]. The latter mechanism can be demonstrated using
potent allosteric inhibitors of phosphorylase which promote
the dephosphorylation of both phosphorylase and synthase
[7^9]. Changes in the activity of phosphorylase in liver cells
have a greater metabolic impact on the rate of glycogen syn-
thesis than can be explained by either cycling between glyco-
gen synthesis and degradation [10] or by the activation state
of glycogen synthase [7]. This raises the question whether
phosphorylase regulates glycogen synthesis by additional
mechanisms.
The ¢rst step in the formation of glycogen is the self-glu-
cosylation of glycogenin, the protein backbone of glycogen, in
which glucosyl residues are transferred from UDP-glucose to
form an oligosaccharide chain of about eight residues [11,12].
This is then elongated by glycogen synthase to form mature
glycogen. Glycogenin was ¢rst puri¢ed from rabbit skeletal
muscle [13] and shown to be present in an equimolar ratio
to glycogen synthase [14]. This isoform, designated glycoge-
nin-1 (38 kDa) is expressed in rabbit liver [15,16]. A higher
molecular weight isoform (60 kDa, glycogenin-2) is expressed
in human liver [17]. Synthesis of glycogen requires the associ-
ation of glycogen synthase and glycogenin, which depends on
the glucosylation state of glycogenin [12]. Glycogenin is regu-
lated by a binding protein that enhances the ability of glyco-
genin to self-glucosylate [18]. Phosphorylase can catalyse the
removal of glucosyl residues from glycogenin [19]. However,
whether this has a physiological role in regulating the initia-
tion of glycogen synthesis has not been tested.
The aim of this study was to test the hypothesis that hor-
mones that a¡ect phosphorylase activity in hepatocytes can
regulate the initiation of glycogen synthesis through changes
in the glucosylation state of glycogenin [19]. Although we
could not detect changes in the glucosylation state of glyco-
genin following hormonal treatment, we found changes in the
association of glycogen synthase with a protein-bound sub-
strate. This suggests that phosphorylase like glucose 6-P reg-
ulates not only the phosphorylation state of glycogen synthase
but also its compartmentation.
2. Materials and methods
2.1. Hepatocyte isolation and culture
Hepatocytes were isolated from male Wistar rats (body weight 180^
280 g) fed ad libitum [20]. They were cultured in minimum essential
medium (MEM) containing 7% (v/v) newborn calf serum in 6-well
plates and after attachment (4 h) the medium was replaced by se-
rum-free MEM containing 10 nM dexamethasone and 5 mM glucose.
The muscle isoform of phosphorylase was expressed using recombi-
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nant adenovirus [21] as described previously [7]. Incubations for de-
termination of the e¡ects of hormones on enzyme activity or glycogen
synthesis were performed after 18 h culture. For determination of
enzyme activity the hepatocyte monolayers were snap-frozen in liquid
N2 and stored at 370‡C. For determination of glycogen synthesis
hepatocytes were incubated in medium containing 25 mM glucose
and [U-14C]glucose (2 WCi/ml) for 3 h. Glycogen was isolated by
ethanol precipitation [20] and glycogen synthesis is expressed as
nmol of glucose incorporated/3 h per mg protein.
2.2. Enzyme activity determination
Glycogenin was assayed by the method of Ercan and colleagues
[22]. Hepatocytes were extracted (1 mg protein/150 Wl) by sonication
in 100 mM NaF, 50 mM L-glycerophosphate, 5 mM EDTA, 2 mM
EGTA, 10 mM dithiothreitol (DTT), pH 7.6 [22]. Glycogenin activity
was determined by diluting 1:2 in medium containing (¢nal concen-
trations): 10 mM MnCl2, 0.12% octylglucoside, 21 mM L-glycero-
phosphate, 3 mM DTT, pH7.6 without or with 2 M LiBr to inhibit
glycogen synthase [23] and UDP[1-3H]glucose at ¢nal concentrations
of 5 WM UDP-glucose (1500^3000 dpm/pmol) or 80 WM UDP-glucose
(650^900 dpm/pmol). For electrophoresis UDP[1-14C]glucose was
used (5 WM, 9000 dpm/pmol). The assay was performed at 30‡C for
5 min or 15 min and was stopped with an equal volume of ice-cold
20% trichloroacetic acid (TCA) and centrifugation at 13 000Ug
(5 min). The pellet was washed twice with 20% TCA, dissolved in
formic acid and the radioactivity determined. Activity was expressed
as pmol/mg protein based on the speci¢c activity of UDP-glucose
which was corrected for endogenous UDP-glucose (assayed as in
[24]). Sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(10% SDS^PAGE gels with a 4% stacking gel) was used to analyse
the glycogenin reaction mixture at the end of the incubation with
UDP[1-14C]glucose. The protein was transferred to nitrocellulose
membrane and exposed to Fuji BAS 2050 phosphor screen for 2^4
days. For determination of glycogen synthase cells were extracted as
in [25] and activity was determined in the homogenates, 13 000Ug
(10 min) supernatant and pellet fractions by a modi¢cation of [25],
with 1 mM UDP-glucose and 10 mM glucose 6-P. The reaction was
started by addition of 1 mM UDP[1-3H]glucose (50^200 dpm/pmol)
and 0.66% glycogen and was stopped after 10 min by precipitation of
protein with TCA as in the glycogenin assay. The soluble fraction was
spotted on Whatman 31 ET chromatography as in the conventional
assay [25] whereas the TCA-insoluble fraction was treated as in the
glycogenin assay. The a⁄nity of glycogen synthase for UDP-glucose
was determined as in [2]. Apparent Vmax values were estimated from
Eadie plots and S0:5 values were determined from Hill plots [2]. For
determination of the activity ratio (3/+ glucose 6-P) assays were
performed without or with glucose 6-P [25]. Phosphorylase a was
assayed spectrometrically [7]. In experiments involving overexpression
of muscle phosphorylase assays were performed with 0.2 mM AMP or
5 mM AMP to determine active and total enzyme, respectively [7].
Activities are expressed as mU/mg cell protein. Results are expressed
as meansPS.E.M. for the number of hepatocyte preparations indi-
cated. Statistical analysis was by the paired t-test.
3. Results
3.1. E¡ects of Mn2+ and glucose 6-P on glycogenin-like
activity in hepatocyte extracts
The self-glucosylation of glycogenin is conventionally as-
sayed from the Mn2þ-dependent incorporation of labelled
UDP[14C/3H]glucose into a TCA-insoluble fraction at 5 WM
or 80 WM UDP-glucose [17,22,23]. In this study the incorpo-
ration of label from 5 WM UDP[14C]glucose into a TCA-in-
soluble fraction was stimulated by Mn2þ and also by glucose
6-P. In the presence of Mn2þ the labelling coincided with
proteins of 30^70 kDa whereas in the presence of glucose
6-P it was associated with high molecular weight fractions
that did not enter the SDS gel (Fig. 1A). Mn2þ-dependent
activity accounted for 60^80% of total activity at 5 WM
UDP-glucose (Fig. 1B) and 6 30% at 80 WM UDP-glucose
(control, 19 P 4; 10 mM Mn2þ, 27 P 4, n=4, pmol/5 min per
mg). Insulin or glucagon pre-treatment of the cells had no
signi¢cant e¡ect on the Mn2þ-dependent activity (Fig. 1B).
However, the Mn2þ-independent activity was increased by
insulin in both the absence and presence of glucose 6-P and
decreased by glucagon in the presence of glucose 6-P (Fig. 1B).
In the combined presence of Mn2þ and glucose 6-P the stim-
ulation was not additive (control, 1.9 P 0.3, glucose 6-P, 3.5 P
0.4; Mn2þ, 6.2 P 0.3; glucose 6-P+Mn2þ 5.8P 0.6 pmol/5 min
per mg), suggesting that Mn2þ may inhibit synthase activity
or that glucose 6-P may inhibit glycogenin-like activity. The
stimulation of label incorporation by glucose 6-P suggests that
it represents glycogen synthase. This was con¢rmed using
LiBr (an inhibitor of synthase but not glycogenin [23]), which
inhibited activity by 91P 3% (n=11) in the absence of Mn2þ
but caused little inhibition (7 P 6%) in the presence of Mn2þ.
The Mn2þ-dependent LiBr-insensitive activity was inhibited
by 56P 10% with 10 mM CDP, an inhibitor of glycogenin
[26]. Time course studies showed that label incorporation
reached a plateau within 15 min (Fig. 1C). This was not
due to substrate depletion during the assay, as con¢rmed by
lack of further incorporation after re-addition of substrate at
the end of the incubation (results not shown). There was no
e¡ect of pre-treatment with insulin for 4 h on net glucosyla-
tion (Fig. 1C). When the e¡ects of hormones or inhibitors
were tested for di¡erent incubation times, and glucosylation
was assayed at 5 min or 15 min there was no e¡ect of: 100 nM
glucagon (5^240 min); 10 nM insulin (1^8 h); 25 mM glucose
Fig. 1. Mn2þ-dependent glycogenin-like activity. A: Radiogram of hepatocyte extracts incubated with UDP[14C]glucose without (1) or with 10
mM Mn2þ (2) or 10 mM glucose 6-P (3) and separated by SDS^gel electrophoresis. B: Hepatocytes were incubated for 1 h without (open
bars) or with 10 nM insulin (hatched bar) or 100 nM glucagon (solid bar) and glycogenin activity was assayed with 5 WM UDP-glucose as de-
scribed in Section 2: without (control) or with 10 mM Mn2þ or 10 mM glucose 6-P. C: Time course of incorporation of UDP[1-3H]glucose in
the presence of 10 mM Mn2þ and 2 M LiBr at either 5 WM (a, b) or 80 WM (E, F) UDP-glucose in cells that were pre-incubated for 4 h with-
out (a, E) or with (b, F) 10 nM insulin. MeansPS.E.M. for n=4^5. *P6 0.05; **P6 0.005 relative to no hormones.
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(16 h); or 150 WM resorcinol (60 min), which causes inactiva-
tion of phosphorylase [27] (results not shown). The activity of
phosphorylase a was increased by glucagon and decreased by
insulin and resorcinol (control, 8.9 P 1.2; glucagon 30.5 P 2.2,
P6 0.01; insulin, 7.3 P 1.0, P6 0.03; resorcinol, 2.9 P 0.7,
P6 0.01; n=5, mU/mg protein). The only treatment that af-
fected glucosylation was 20 mM glucosamine (1 h), which
inhibited by 50% (4.6 P 0.7 to 2.4P 0.4, pmol/5 min per mg
protein, n=6, P6 0.003). This inhibition was reversible after
washout of glucosamine (results not shown).
3.2. Glycogen synthase activity associated with TCA-insoluble
and TCA-soluble products
To investigate the underlying mechanism for the e¡ects of
hormones on the Mn2þ-independent glucosylation of a TCA-
insoluble substrate, glycogen synthase was assayed by a mod-
i¢cation of the conventional assay for glycogen synthase [25]
using 1 mM UDP-glucose and 10 mM glucose 6-P, and on
termination of the assay the labelled product was separated
into TCA-soluble and TCA-insoluble fractions. For this assay
the speci¢c activity of UDP[1-3H]-glucose was 10-fold lower
than in the glycogenin assay and there was no interference
from glycogenin activity, as con¢rmed by total inhibition by
LiBr, which inhibits glycogen synthase but not glycogenin
[23]. The label incorporated from UDP[1-3H]glucose into
the TCA-insoluble fraction was expressed as a percentage of
labelling of TCA-soluble glycogen. Since glycogen synthase
translocates from the supernatant to the pellet fraction follow-
ing incubation with glucose [5] assays were performed on
whole homogenates and on supernatant and pellet fractions.
In assays on the whole homogenates (Fig. 2, open bars) the
radiolabelled product from the synthase assay that was recov-
ered in the TCA-insoluble fraction was signi¢cantly increased
by insulin, 25 mM glucose and resorcinol and decreased by
glucagon. When total glycogen synthase assays was assayed
on the supernatant and pellet fractions, we con¢rmed a sim-
ilar translocation of enzyme from the supernatant to the pellet
fraction after incubation with 25 mM glucose (control, 67 P 3;
glucose, 58P 3, P6 0.05, n=5, supernatant % total) as re-
ported previously [5]. However, insulin, glucagon or resorci-
nol did not signi¢cantly a¡ect translocation (not shown). Fig.
2A shows the activity in the TCA-insoluble fraction relative to
the TCA-soluble fraction for the supernatant (solid bars) and
13 000Ug pellet fractions (hatched bars). The e¡ects of insu-
lin, glucagon and resorcinol on the glycogen synthase activity
associated with the TCA-insoluble product were observed in
the pellet (hatched bars) but not in the supernatant fractions
(solid bars, Fig. 2A). The action of glucagon on the TCA-
insoluble fraction was rapid (complete within 5^15 min Fig.
2B) and similar to the activation of phosphorylase and inac-
tivation of synthase in the TCA-soluble fraction, which were
complete within 5 min (Fig. 2C).
3.3. Synthase activity associated with acid-insoluble glycogen
has a higher a⁄nity for UDP-glucose
The a⁄nity of synthase for UDP-glucose was determined in
whole homogenates and the assay product was separated into
the TCA-insoluble and TCA-soluble fractions (Table 1). For
all treatments the apparent S0:5 for UDP-glucose was lower in
the TCA-insoluble fraction (P6 0.01) con¢rming that this la-
belling is not an artefact due to non-speci¢c entrapment of
glycogen in a protein pellet. The apparent Vmax of the TCA-
insoluble fraction was increased by insulin and resorcinol and
decreased by glucagon (Table 1), con¢rming that glucagon
Fig. 2. A: Glycogen synthase activity in hepatocyte homogenates, supernatants and pellets determined by separation of the product into TCA-
insoluble and TCA-soluble fractions. Hepatocytes were incubated for 1 h in medium without (control) or with 10 nM insulin, 100 nM gluca-
gon, 150 WM resorcinol or 25 mM glucose. Glycogen synthase was assayed in whole homogenates (open bars), 13 000Ug supernatant (¢lled
bars) and pellet fractions (hatched bars). On termination of the assay the product was separated into acid-soluble and acid-insoluble fractions
and the synthase activity associated with the TCA-insoluble fraction is expressed as % of the TCA-soluble fraction. MeansPS.E.M. n=7^25
*P6 0.05, **P6 0.01 relative to control. B,C: E¡ects of incubation of hepatocytes with glucagon on: synthase activity associated with the
TCA-insoluble fraction (B) and on phosphorylase a and glycogen synthase activity ratio in the TCA-soluble fraction (C). MeansPS.E.M. n=5.
Table 1
The a⁄nity of glycogen synthase for UDP-glucose determined after separation of the product into TCA-insoluble and TCA-soluble fractions
Addition: Control Insulin Glucagon Resorcinol
TCA-insoluble: S0:5 (WM) 316P 12 376P 36 687P 69* 234P 9**
TCA-insoluble: Vmax (mU/mg) 0.14P 0.02 0.19P 0.03* 0.06P 0.01** 0.24P 0.04*
TCA-soluble: S0:5 (WM) 1551P 188 1448P 130 2711P 211 744P 105
TCA-soluble: Vmax (mU/mg) 1.01P 0.12 1.09P 0.10 1.04P 0.20 0.90P 0.09
Hepatocyte monolayers were incubated for 1 h without or with 10 nM insulin, 100 nM glucagon or 150 WM resorcinol. Glycogen synthase ac-
tivity was determined in homogenates in the presence of 10 mM glucose 6-P and varying concentrations of UDP-glucose and the product was
separated into TCA-insoluble and TCA-soluble fractions. S0:5 for UDP-glucose were determined from Hill plots. Values are meansPS.E.M.
n=4^6. *P6 0.05, **P6 0.01 relative to control.
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causes dissociation whereas insulin and resorcinol cause in-
creased association.
3.4. Phosphorylase overexpression mimics the e¡ect of
glucagon
To determine whether the e¡ect of glucagon on dissociation
of synthase from a TCA-insoluble substrate can be explained
by the increase in phosphorylase activity we tested the e¡ect
of expression of the muscle isoform of phosphorylase using
recombinant adenovirus [21]. This isoform unlike the liver
isoform is catalytically active in hepatocytes in the dephos-
phorylated state because of activation by physiological AMP
concentrations [7]. Expression of muscle phosphorylase was
associated with inhibition of glycogen synthesis (Fig. 3B)
and with a decrease in synthase activity on the TCA-insoluble
substrate of around 50% (Fig. 3C).
4. Discussion
In this study we found no evidence for hormone-mediated
changes in the glucosylation state of glycogenin, as deter-
mined from the Mn2þ-dependent glucosylation of a TCA-in-
soluble fraction by the conventional glycogenin assay [22,23].
However, using a modi¢ed assay for glycogen synthase, we
provide evidence for hormone-dependent changes in the asso-
ciation of glycogen synthase with a proteoglycogen (TCA-in-
soluble) substrate. The conventional glycogen synthase assay
does not distinguish between acid-soluble and acid-insoluble
(protein-bound) substrates [25]. By separating the reaction
product into TCA-soluble and TCA-insoluble fractions we
demonstrate that activity associated with the latter substrate
accounts for between 5 and 25% of total activity, depending
on the hormonal conditions and has a higher a⁄nity for
UDP-glucose than the synthase associated with the acid-solu-
ble substrate.
Previous studies on hepatocytes have shown that high glu-
cose concentration causes translocation of glycogen synthase
from the 13 000Ug supernatant to the pellet fraction by a
glucose 6-P-dependent mechanism [5]. This was con¢rmed in
this study. In addition we also show that whereas hormones
have negligible e¡ect on translocation of synthase between the
13 000Ug supernatant and the pellet, they cause translocation
of synthase within the 13 000Ug pellet between a fraction that
acts on acid-soluble ‘glycogen’ and a fraction associated with
an acid-insoluble glycogen substrate, which presumably has a
higher protein/glycogen ratio. This indicates that there are two
distinct translocation mechanisms: a glucose 6-P-dependent
mechanism that involves translocation from the soluble to
the 13 000Ug particulate fraction and a hormone-mediated
mechanism that regulates binding or dissociation from pro-
teoglycogen within the 13 000Ug pellet. It is noteworthy that
although the glycogen synthase assays in this study contained
exogenous glycogen, additional experiments in which the gly-
cogen was omitted showed similar labelling of the acid-insolu-
ble fraction and lower but signi¢cant labelling (30^40%) of the
acid-soluble fraction in both the supernatant and pellet frac-
tions. This indicates that whereas labelling of the acid-insolu-
ble fraction is entirely due to an endogenous substrate, the
labelling of the acid-soluble fraction is in part due to endog-
enous glycogen and in part to the exogenous glycogen added
in the assay.
Recent studies on bovine retina have demonstrated two
activities of glycogen synthase associated with acid-soluble
glycogen and acid-insoluble proteoglycogen [28]. The latter
fraction had a higher a⁄nity for UDP-glucose [28] and con-
tained glycogenin [29]. The synthase associated with the acid-
insoluble glycogen may either be a distinct enzyme or alter-
natively its higher a⁄nity for UDP-glucose may be a conse-
quence of a di¡erence in structure of the polysaccharide moi-
ety [28]. The present ¢ndings are analogous to those on
bovine retina in that the synthase associated with the acid-
insoluble substrate has a higher a⁄nity for UDP-glucose and
is con¢ned to the particulate fraction, which also contained
the ‘glycogenin-like’ activity. In addition the present study
shows that glucagon causes dissociation of glycogen synthase
from the proteoglycogen fraction whereas resorcinol, which
causes inactivation of phosphorylase, has the converse e¡ect
and phosphorylase overexpression mimics the e¡ect of gluca-
gon. These ¢ndings argue in support of a role of phosphor-
ylase activity in regulating the binding of synthase to a pro-
teoglycogen substrate.
Although we found no evidence for hormone-mediated
changes in glycogenin activity determined by a Mn2þ-depen-
dent assay that has been used previously on liver and other
tissues [22,23], which argues against a role for phosphorylase
in regulating glycogenin activity, we found 50% inhibition of
glycogenin-like activity by pre-treatment of hepatocytes with
20 mM glucosamine. Since glucosamine has been shown to be
a minor component of rabbit and pig liver glycogen [30], the
inhibition could be due to incorporation of glucosamine into
Fig. 3. Expression of muscle phosphorylase in hepatocytes inhibits glycogen synthesis and dissociates glycogen synthase from the TCA-insoluble
fraction. Hepatocytes were either untreated (solid symbols) or treated (open symbols) with three titres of recombinant adenovirus AdCMV-
MGP for expression of muscle phosphorylase. A: Phosphorylase activity assayed with 0.2 mM AMP (a, b) or 5 mM AMP (E, F). B: Glyco-
gen synthesis determined during a 3 h incubation with 25 mM glucose. C: Glycogen synthesis (a) and glycogen synthase activity associated
with the TCA-insoluble fraction (E) in cells expressing muscle phosphorylase expressed as % of untreated controls. MeansPS.E.M. n=4.
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the glucosyl chain and this may inhibit the further incorpo-
ration of glucosyl residues during incubation with UDP-glu-
cose in the conventional assay. An alternative possibility is
that glucosamine may inactivate glycogenin by glucosylation
of serine or threonine residues after conversion to N-acetyl-
glucosamine, as was recently suggested for inactivation of
glycogen synthase by glucosamine [31].
A tentative hypothesis to explain the hormone-mediated
changes in translocation of glycogen synthase to a TCA-in-
soluble substrate, is that the proteoglycogen fraction repre-
sents nascent glycogen particles and that metabolic conditions
associated with increased phosphorylase activity cause disso-
ciation of glycogen synthase and consequent inhibition of gly-
cogen synthesis. The higher a⁄nity for UDP-glucose of the
synthase associated with the acid-insoluble proteoglycogen
could be explained by either a di¡erence in structure of the
polysaccharide substrate as suggested for retina [28] or by the
presence glycogen-targeting proteins and synthase phospha-
tase activity in the proteoglycogen particle, which promote
the dephosphorylation of synthase. The glycogen-targeting
protein, designated PTG, has a binding site at the C-terminus
that can bind glycogen synthase or phosphorylase a by a
mutually exclusive mechanism [32]. Association of this target-
ing protein with proteoglycogen may provide a mechanism for
competitive binding between phosphorylase a and glycogen
synthase promoting inhibition or initiation of glycogen syn-
thesis, respectively. It might also explain the lower phosphor-
ylation state (higher a⁄nity for UDP-glucose) of glycogen
synthase associated with the proteoglycogen fraction. The
changes in association of synthase with the proteoglycogen
substrate might also result from changes in the amount of
the endogenous acid-insoluble acceptor, because of transloca-
tion of enzymes to or from nascent glycogen particles.
It is often assumed that concurrent activity of phosphory-
lase a and glycogen synthase as determined in the convention-
al assays is indicative of cycling between glycogen synthesis
and degradation [33,34]. However, studies using an inhibitor
of glycogen phosphorylase provided evidence against cycling
in various liver preparations [35]. The present ¢nding that
phosphorylase regulates the compartmentation of glycogen
synthase provides a potential explanation for the lack of gly-
cogen cycling in metabolic states associated with simultaneous
activities of glycogen synthase and phosphorylase, since under
conditions of elevated phosphorylase activity there would be
inhibition of initiation of glycogen synthesis through dissoci-
ation of glycogen synthase from the proteoglycogen particles.
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